ADA has also been proposed as a biomarker and possible therapeutic target for a number of inflammatory conditions, including rheumatoid arthritis, cardiovascular disease, inflammatory bowel disease, and bacterial infection [42–45]. This evidence concerns the gene ADA and inflammatory bowel disease.